WO1998053043A1 - Method and apparatus for determining nonparaffinophilic microorganisms - Google Patents

Method and apparatus for determining nonparaffinophilic microorganisms Download PDF

Info

Publication number
WO1998053043A1
WO1998053043A1 PCT/US1998/009421 US9809421W WO9853043A1 WO 1998053043 A1 WO1998053043 A1 WO 1998053043A1 US 9809421 W US9809421 W US 9809421W WO 9853043 A1 WO9853043 A1 WO 9853043A1
Authority
WO
WIPO (PCT)
Prior art keywords
grams
aqueous solution
distilled water
carbon source
solution includes
Prior art date
Application number
PCT/US1998/009421
Other languages
French (fr)
Inventor
Robert A. Ollar
Mitchell S. Felder
Original Assignee
Infectech, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Infectech, Inc. filed Critical Infectech, Inc.
Priority to AU73739/98A priority Critical patent/AU7373998A/en
Publication of WO1998053043A1 publication Critical patent/WO1998053043A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00—Constructional details, e.g. recesses, hinges
    • C12M23/02—Form or structure of the vessel
    • C12M23/08—Flask, bottle or test tube
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/26—Processes using, or culture media containing, hydrocarbons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/14—Streptococcus; Staphylococcus

Definitions

  • This invention relates to a method of determining the presence or absence of a nonparaffinophilic microorganism in a specimen and an associated apparatus.
  • nonparaffinophilic microorganism means any microorganism sustained by a carbon source other than paraffin. Examples of such
  • nonparaffinophilic microorganisms include, but are not limited to, the following: Mycobacterium tuberculosis; Mycobacterium paratuberculosis ; Mycobacterium leprae; Staphylococcus; Streptococcus; E. coli ; Listeria; Brucellae; Humemophilus; Treponema; Pneumococcus ;
  • the term "patient” refers to a member of the animal kingdom, including human beings, whose body specimen is being processed by the method and apparatus of the invention.
  • United States Patent Nos . 5,153,119 and 5,316,918 disclose methods and apparatus for identifying and testing the antibiotic sensitivity of Mycobacteri um avi u - in tracel l ulare ("MAI"), a paraffinophilic microorganism.
  • MAI Mycobacteri um avi u - in tracel l ulare
  • the inventor named on those patents is Robert-A. Ollar, one of the co-inventors of the invention disclosed herein. This method involves providing a receptacle containing an aqueous solution and inoculating into the solution a specimen. After this, a paraffin coated slide is placed into the receptacle. The slide is then observed for the presence or absence of growth of MAI.
  • Dr. Ollar' s patents there still remains a need for a simple and effective method to determine the presence or absence of a nonparaffinophilic microorganism.
  • a method of determining the presence or absence of a nonparaffinophilic microorganism in a specimen taken from a patient comprises providing a receptacle containing an aqueous solution that does not contain a carbon source and inoculating the aqueous solution with the specimen. A slide having bound thereto a carbon source is placed into the receptacle. By analyzing the slide after exposure to the specimen, the presence or absence of a nonparaffinophilic microorganism in the specimen can be determined.
  • the apparatus comprises a receptacle for holding an aqueous solution that does not contain a carbon source and a slide having bound thereto a carbon source adapted to be placed in the receptacle.
  • the carbon source can be included in a gelatinous matrix which is bound to the slide or can be an ionically or affinity bound carbon source bound to a plurality of gel beads that are themselves adhered to the slide .
  • the method and apparatus of the invention provide an efficient, effective and economical way of identifying a nonparaffinophilic microorganism.
  • a nonparaffinophilic microorganism identification apparatus 10 includes a standard test tube 12 which contains an aqueous solution 13 (such as Czapek broth) and a cotton plug 16 to seal the test tube 12.
  • a specimen to be tested for the presence or absence of a nonparaffinophilic microorganism is inoculated into the aqueous solution 13.
  • a slide 18 having bound thereto a carbon source 20 is then placed into the test tube 12.
  • the aqueous solution 13 should not contain any carbon source, as it is desired to provide a sole carbon source 20 on the slide 18 in order to effectively grow the nonparaffinophilic microorganism to be identified on the slide 18 and not in the aqueous solution 13.
  • Growth on the slide 18, which can either be seen or unseen by the unaided human eye, can be analyzed to determine the presence or absence of a nonparaffinophilic microorganism.
  • a minimum of twenty-four (24) hours incubation time is necessary for growth to occur.
  • the slide 18 can be scraped using a flame sterilized spatula and subcultured on an agar-like tryptic soy agar ("TSA") . If the scrapings include growth, the growth on the TSA can be analyzed using classical microbiological procedures or can be analyzed using a DNA extraction process involving either organic solvent extraction or column chromatographic extraction.
  • the specimen to be inoculated into the test tube 12 can be a blood sample; any biopsy or tissue specimen; stomach fluid; urine; cerebral spinal fluid; nasopharyngeal mucosa or saliva. These specimens can be obtained from the patient in the doctor's office or in the emergency room of a hospital, for example, by known techniques in known standard ways .
  • the carbon source 20 on the slide 18 can include a gelatinous matrix containing a carbon source.
  • a carbon source can be one or more of those selected from the group consisting of glucose, fructose, glycerol , mannitol, asparagine, casein, adonitol, 1-arabinose, cellobiose, dextrose, dulcitol, d-galactose, inositol, inulin, lactose, levulose ( - fructose) , maltose, d-mannitol, d-mannose, melibiose, raffinose, rhamnose, sucrose, salicin, d-sorbitol, trehalose and d-xylose, among others .
  • Another embodiment can include providing a slide and coating the slide with an adhesive and securing a plurality of gel beads to the adhesive.
  • the carbon source can then be either ionically or affinity bound to the gel beads.
  • the slide 18 with the gelatinous matrix containing a carbon source can be prepared by the following method.
  • a receptacle such as a laboratory beaker, is first filled with 100 ml of distilled water.
  • a receptacle such as a laboratory beaker
  • a carbon source such as glucose
  • a sterile slide 18 is dropped into the molten gelatinous matrix/carbon source and becomes coated therewith.
  • the now coated slide is removed from the petri dish and allowed to stand for a minute or two in order to solidify the coating 20 thereon.
  • the slide with the coating of a gelatinous matrix containing a carbon source is then ready to be placed in the test tube 12 containing the aqueous solution 13 and the specimen.
  • An alternative method of preparing the slide involves first coating the slide with an adhesive, such as collodion and then applying a plurality of gel beads (commercially available from Pharmacia of Parsippany, New Jersey) to the adhesive.
  • the gel beads are approximately one micron in diameter.
  • Nonparaffinophilic microorganisms that can be identified using the method of the invention include any microorganism sustained by a carbon source other than paraffin.
  • Nonparaffinophilic microorganisms include, but are not limited to, Mycobacterium tuberculosis ; Mycobacterium paratuberculosis ; Mycobacterium leprae; Staphylococcus; Streptococcus; E. coli ; Listeria; Brucellae; Humemophilus; Treponema ; Pneumococcus ;
  • a receptacle containing an aqueous solution comprising:
  • Phenol Red 0.025 grams is prepared. A specimen from each patient is inoculated into the receptacle. After this, a slide with bound d-mannitol thereon is placed into the receptacle. After a period of time, if a growth is not observed on the slide, the doctor determines that staphylococcus aureus is not present. If a growth is detected within a predetermined period of time, the doctor can be fairly sure that staphylococcal growth is present. Further confirmation of this identification can be made by conventional or molecular based systems.
  • EXAMPLE 2 A patient visits a doctor with symptoms which the doctor believes indicates the presence of streptococcus pneumoniae .
  • a receptacle containing an aqueous solution comprising:
  • NaCl 5 grams is prepared. A specimen from each patient is inoculated into the receptacle. After this, a slide with bound dextrose thereon is placed into the receptacle. After a period of time, if a growth is not observed on the slide, the doctor determines that streptococcus pneumoniae is not present. If a growth is detected within a predetermined period of time, the doctor can be fairly sure that streptococcus pneumoniae growth is present. Further confirmation of this identification can be made by conventional or molecular based systems.
  • a receptacle containing an aqueous solution comprising:
  • Neutral Red 0.025 grams is prepared. A specimen from each patient is inoculated into the receptacle. After this, a slide with bound lactose thereon is placed into the receptacle. After a period of time, if a growth is not observed on the slide, the doctor determines that shigella spp . is not present. If a growth is detected within a predetermined period of time, the doctor can be fairly sure that shigella spp . growth is present. Further confirmation of this identification can be made by conventional or molecular based systems.
  • EXAMPLE 4 A patient visits a doctor with symptoms which the doctor believes indicates the presence of salmonella spp . In order to determine the presence or absence of the salmonella spp . , a receptacle containing an aqueous solution comprising: Distilled Water 1 liter
  • Neutral Red 0.025 grams is prepared. A specimen from each patient is inoculated into the receptacle. After this, a slide with bound lactose thereon is placed into the receptacle. After a period of time, if a growth is not observed on the slide, the doctor determines that salmonella spp . is not present. If a growth is detected within a predetermined period of time, the doctor can be fairly sure that salmonella spp . growth is present. Further confirmation of this identification can be made by conventional or molecular based systems . EXAMPLE 5
  • a receptacle containing an aqueous solution comprising:
  • Sodium Selenite 4 grams Sodium Phosphate 10 grams is prepared. A specimen from each patient is inoculated into the receptacle. After this, a slide with bound lactose thereon is placed into the receptacle. After a period of time, if a growth is not observed on the slide, the doctor determines that salmonella is not present. If a growth is detected within a predetermined period of time, the doctor can be fairly sure that salmonella growth is present. Further confirmation of this identification can be made by conventional or molecular based systems.
  • E. coli a receptacle containing an aqueous solution comprising:
  • Brom Cresol Purple 0.01 grams is prepared. A specimen from each patient is inoculated into the receptacle. After this, a slide with bound lactose thereon is placed into the receptacle. After a period of time, if a growth is not observed on the slide, the doctor determines that E. coli is not present. If a growth is detected within a predetermined period of time, the doctor can be fairly sure that E. coli growth is present. Further confirmation of this identification can be made by conventional or molecular based systems.
  • a receptacle containing an aqueous solution comprising:
  • Brom Cresol Purple 0.01 grams is prepared. A specimen from each patient is inoculated into the receptacle. After this, a slide with bound sorbitol thereon is placed into the receptacle. After a period of time, if a growth is not observed on the slide, the doctor determines that E. coli (0157) is not present. If a growth is detected within a predetermined period of time, the doctor can be fairly sure that E. coli (0157) growth is present. Further confirmation of this identification can be made by conventional or molecular based systems .
  • a receptacle containing an aqueous solution comprising:
  • Phenol Red 0.012 grams is prepared. A specimen from each patient is inoculated into the receptacle. After this, a slide with bound dextrose thereon is placed into the receptacle. After a period of time, if a growth is not observed on the slide, the doctor determines that helicobacter pylori is not present. If a growth is detected within a predetermined period of time, the doctor can be fairly sure that helicobacter pylori growth is present. Further confirmation of this identification can be made by conventional or molecular based systems.
  • EXAMPLE 9 A patient visits a doctor with symptoms which the doctor believes indicates the presence of klebsiella pneumoniae. In order to determine the presence or absence of the klebsiella pneumoniae, a receptacle containing an aqueous solution comprising: Distilled Water 1 liter
  • Dipotasium Phosphate 2 grams Eosin Y 0.4 grams Methylene Blue 0.065 grams is prepared. A specimen from each patient is inoculated into the receptacle. After this, a slide with bound sucrose thereon is placed into the receptacle. After a period of time, if a growth is not observed on the slide, the doctor determines that klebsiella pneumoniae is not present. If a growth is detected within a predetermined period of time, the doctor can be fairly sure that klebsiella pneumoniae growth is present. Further confirmation of this identification can be made by conventional or molecular based systems.

Abstract

A method of determining the presence or absence of a nonparaffinophilic microorganism in a specimen taken from a patient includes providing a receptacle containing an aqueous solution that does not contain a carbon source and inoculating the aqueous solution with the specimen. A slide having bound thereto a carbon source is placed into the receptacle. By analyzing the slide after exposure to the specimen, the presence or absence of a nonparaffinophilic microorganism in the specimen can be determined. An associated apparatus is also disclosed.

Description

"METHOD AND APPARATUS FOR DETERMINING NONPARAFFINOPHILIC MICROORGANISMS."
CROSS-REFERENCE TO RELATED APPLICATION
This is a continuation- in-part of U.S. Patent Application Serial No. 08/528,189 filed September 14, 1995.
5 BACKGROUND OF THE INVENTION
This invention relates to a method of determining the presence or absence of a nonparaffinophilic microorganism in a specimen and an associated apparatus.
10 Identification of nonparaffinophilic microorganisms in a clinical specimen is an important part of medical treatment of patients. Often times, educated guesses as to the nature of the microorganism involved are made. It thus would be beneficial to improve the process
15 of identifying these microorganisms with a simple, effective method and apparatus.
As used herein, the term "nonparaffinophilic microorganism" means any microorganism sustained by a carbon source other than paraffin. Examples of such
20 nonparaffinophilic microorganisms include, but are not limited to, the following: Mycobacterium tuberculosis; Mycobacterium paratuberculosis ; Mycobacterium leprae; Staphylococcus; Streptococcus; E. coli ; Listeria; Brucellae; Humemophilus; Treponema; Pneumococcus ;
25 Clostridium; Cryptococcus ; Coccidioideε; Histoplas a; Klebsiella pneu oniae ; Shigella spp. ; Salmonella spp. ; Salmonella; E. coli (0157) ; and Helicobacter pylori . Also, as used herein, the term "patient" refers to a member of the animal kingdom, including human beings, whose body specimen is being processed by the method and apparatus of the invention.
United States Patent Nos . 5,153,119 and 5,316,918 disclose methods and apparatus for identifying and testing the antibiotic sensitivity of Mycobacteri um avi u - in tracel l ulare ("MAI"), a paraffinophilic microorganism. The inventor named on those patents is Robert-A. Ollar, one of the co-inventors of the invention disclosed herein. This method involves providing a receptacle containing an aqueous solution and inoculating into the solution a specimen. After this, a paraffin coated slide is placed into the receptacle. The slide is then observed for the presence or absence of growth of MAI.
Despite the efficient, effective and economical method disclosed in Dr. Ollar' s patents, there still remains a need for a simple and effective method to determine the presence or absence of a nonparaffinophilic microorganism.
SUMMARY OF THE INVENTION
The invention has met or exceeded the above-mentioned needs as well as others. A method of determining the presence or absence of a nonparaffinophilic microorganism in a specimen taken from a patient comprises providing a receptacle containing an aqueous solution that does not contain a carbon source and inoculating the aqueous solution with the specimen. A slide having bound thereto a carbon source is placed into the receptacle. By analyzing the slide after exposure to the specimen, the presence or absence of a nonparaffinophilic microorganism in the specimen can be determined.
An associated apparatus is also disclosed. The apparatus comprises a receptacle for holding an aqueous solution that does not contain a carbon source and a slide having bound thereto a carbon source adapted to be placed in the receptacle. The carbon source can be included in a gelatinous matrix which is bound to the slide or can be an ionically or affinity bound carbon source bound to a plurality of gel beads that are themselves adhered to the slide .
BRIEF DESCRIPTION OF THE DRAWING A full understanding of the invention can be gained from the following detailed description of the invention when read in conjunction with the accompanying lone drawing which shows a front elevational view of a test tube holding a slide coated with a carbon source in an aqueous solution inoculated with a specimen.
DETAILED DESCRIPTION
The method and apparatus of the invention provide an efficient, effective and economical way of identifying a nonparaffinophilic microorganism. Referring now to the lone Figure, an embodiment of a nonparaffinophilic microorganism identification apparatus 10 is shown. The apparatus 10 includes a standard test tube 12 which contains an aqueous solution 13 ( such as Czapek broth) and a cotton plug 16 to seal the test tube 12. According to the invention, a specimen to be tested for the presence or absence of a nonparaffinophilic microorganism is inoculated into the aqueous solution 13. A slide 18 having bound thereto a carbon source 20 is then placed into the test tube 12. It will be appreciated that the aqueous solution 13 should not contain any carbon source, as it is desired to provide a sole carbon source 20 on the slide 18 in order to effectively grow the nonparaffinophilic microorganism to be identified on the slide 18 and not in the aqueous solution 13. Growth on the slide 18, which can either be seen or unseen by the unaided human eye, can be analyzed to determine the presence or absence of a nonparaffinophilic microorganism. Preferably, a minimum of twenty-four (24) hours incubation time is necessary for growth to occur. In order to analyze the slide 18 after the incubation period, the slide 18 can be scraped using a flame sterilized spatula and subcultured on an agar-like tryptic soy agar ("TSA") . If the scrapings include growth, the growth on the TSA can be analyzed using classical microbiological procedures or can be analyzed using a DNA extraction process involving either organic solvent extraction or column chromatographic extraction. The specimen to be inoculated into the test tube 12 can be a blood sample; any biopsy or tissue specimen; stomach fluid; urine; cerebral spinal fluid; nasopharyngeal mucosa or saliva. These specimens can be obtained from the patient in the doctor's office or in the emergency room of a hospital, for example, by known techniques in known standard ways .
The carbon source 20 on the slide 18 can include a gelatinous matrix containing a carbon source. A carbon source can be one or more of those selected from the group consisting of glucose, fructose, glycerol , mannitol, asparagine, casein, adonitol, 1-arabinose, cellobiose, dextrose, dulcitol, d-galactose, inositol, inulin, lactose, levulose ( - fructose) , maltose, d-mannitol, d-mannose, melibiose, raffinose, rhamnose, sucrose, salicin, d-sorbitol, trehalose and d-xylose, among others . Another embodiment can include providing a slide and coating the slide with an adhesive and securing a plurality of gel beads to the adhesive. The carbon source can then be either ionically or affinity bound to the gel beads. The slide 18 with the gelatinous matrix containing a carbon source can be prepared by the following method. A receptacle, such as a laboratory beaker, is first filled with 100 ml of distilled water. Into the beaker is placed two (2) grams of agar (the gelatinous matrix) and three (3) grams of a carbon source ( such as glucose) . This mixture is then boiled and steam sterilized and the molten gelatinous matrix with a carbon source is poured into a petri dish, which is sitting on a hot plate. In this way the gelatinous matrix/carbon source remains molten. After this, a sterile slide 18 is dropped into the molten gelatinous matrix/carbon source and becomes coated therewith. The now coated slide is removed from the petri dish and allowed to stand for a minute or two in order to solidify the coating 20 thereon. The slide with the coating of a gelatinous matrix containing a carbon source is then ready to be placed in the test tube 12 containing the aqueous solution 13 and the specimen. An alternative method of preparing the slide involves first coating the slide with an adhesive, such as collodion and then applying a plurality of gel beads ( commercially available from Pharmacia of Parsippany, New Jersey) to the adhesive. The gel beads are approximately one micron in diameter. The slide containing the coating of gel beads is now immersed in a buffering agent containing the carbon source ( such as glucose) to attach the carbon source to the gel beads either ionically or affinity-wise. Nonparaffinophilic microorganisms that can be identified using the method of the invention include any microorganism sustained by a carbon source other than paraffin. Nonparaffinophilic microorganisms include, but are not limited to, Mycobacterium tuberculosis ; Mycobacterium paratuberculosis ; Mycobacterium leprae; Staphylococcus; Streptococcus; E. coli ; Listeria; Brucellae; Humemophilus; Treponema ; Pneumococcus ;
Clostridium; Cryptococcus ; Coccidioides ; Histoplasma; Klebsiella pneumoniae; Shigella spp . ; Salmonella spp . ; Salmonella; E. coli (0157) ; and Helicobacter pylori .
In order to further elucidate the invention, the following examples are provided.
EXAMPLE 1
A patient visits a doctor with symptoms which the doctor believes indicates the presence of staphylococcus aureus . In order to determine the presence or absence of the staphlococcus aureus, a receptacle containing an aqueous solution comprising:
Distilled Water 1 liter Beef Extract 1 gram
Peptone 10 grams
NaCl 75 grams
Phenol Red 0.025 grams is prepared. A specimen from each patient is inoculated into the receptacle. After this, a slide with bound d-mannitol thereon is placed into the receptacle. After a period of time, if a growth is not observed on the slide, the doctor determines that staphylococcus aureus is not present. If a growth is detected within a predetermined period of time, the doctor can be fairly sure that staphylococcal growth is present. Further confirmation of this identification can be made by conventional or molecular based systems.
EXAMPLE 2 A patient visits a doctor with symptoms which the doctor believes indicates the presence of streptococcus pneumoniae . In order to determine the presence or absence of the streptococcus pneumoniae, a receptacle containing an aqueous solution comprising:
Distilled Water 1 liter
Beef Infusion 450 grams Proteose 20 grams
NaCl 5 grams is prepared. A specimen from each patient is inoculated into the receptacle. After this, a slide with bound dextrose thereon is placed into the receptacle. After a period of time, if a growth is not observed on the slide, the doctor determines that streptococcus pneumoniae is not present. If a growth is detected within a predetermined period of time, the doctor can be fairly sure that streptococcus pneumoniae growth is present. Further confirmation of this identification can be made by conventional or molecular based systems.
EXAMPLE 3
A patient visits a doctor with symptoms which the doctor believes indicates the presence of shigella spp . In order to determine the presence or absence of the shigella spp . , a receptacle containing an aqueous solution comprising:
Distilled Water 1 liter
Beef Extract 5 grams Peptone 5 grams
Bile Salts 8.5 grams
Sodium Citrate 8.5 grams
Sodium Thiosulfate 8.5 grams
Ferric Citrate 1 gram Brilliant Green 0.33 milligrams
Neutral Red 0.025 grams is prepared. A specimen from each patient is inoculated into the receptacle. After this, a slide with bound lactose thereon is placed into the receptacle. After a period of time, if a growth is not observed on the slide, the doctor determines that shigella spp . is not present. If a growth is detected within a predetermined period of time, the doctor can be fairly sure that shigella spp . growth is present. Further confirmation of this identification can be made by conventional or molecular based systems.
EXAMPLE 4 A patient visits a doctor with symptoms which the doctor believes indicates the presence of salmonella spp . In order to determine the presence or absence of the salmonella spp . , a receptacle containing an aqueous solution comprising: Distilled Water 1 liter
Beef Extract 5 grams
Peptone 5 grams
Bile Salts 8.5 grams
Sodium Citrate 8.5 grams Sodium Thiosulfate 8.5 grams
Ferric Citrate 1 gram
Brilliant Green 0.33 milligrams
Neutral Red 0.025 grams is prepared. A specimen from each patient is inoculated into the receptacle. After this, a slide with bound lactose thereon is placed into the receptacle. After a period of time, if a growth is not observed on the slide, the doctor determines that salmonella spp . is not present. If a growth is detected within a predetermined period of time, the doctor can be fairly sure that salmonella spp . growth is present. Further confirmation of this identification can be made by conventional or molecular based systems . EXAMPLE 5
A patient visits a doctor with symptoms which the doctor believes indicates the presence of salmonella . In order to determine the presence or absence of the salmonella, a receptacle containing an aqueous solution comprising :
Distilled Water 1 liter
Tryptone 5 grams
Sodium Selenite 4 grams Sodium Phosphate 10 grams is prepared. A specimen from each patient is inoculated into the receptacle. After this, a slide with bound lactose thereon is placed into the receptacle. After a period of time, if a growth is not observed on the slide, the doctor determines that salmonella is not present. If a growth is detected within a predetermined period of time, the doctor can be fairly sure that salmonella growth is present. Further confirmation of this identification can be made by conventional or molecular based systems.
EXAMPLE 6
A patient visits a doctor with symptoms which the doctor believes indicates the presence of E. coli .
In order to determine the presence or absence of the
E. coli , a receptacle containing an aqueous solution comprising:
Distilled Water 1 liter
Oxgall 5 grams
Peptone 20 grams
Brom Cresol Purple 0.01 grams is prepared. A specimen from each patient is inoculated into the receptacle. After this, a slide with bound lactose thereon is placed into the receptacle. After a period of time, if a growth is not observed on the slide, the doctor determines that E. coli is not present. If a growth is detected within a predetermined period of time, the doctor can be fairly sure that E. coli growth is present. Further confirmation of this identification can be made by conventional or molecular based systems.
EXAMPLE 7
A patient visits a doctor with symptoms which the doctor believes indicates the presence of
E . coli (0157) . In order to determine the presence or absence of the E. coli (0157) , a receptacle containing an aqueous solution comprising:
Distilled Water 1 liter Oxgall 5 grams
Peptone 20 grams
Brom Cresol Purple 0.01 grams is prepared. A specimen from each patient is inoculated into the receptacle. After this, a slide with bound sorbitol thereon is placed into the receptacle. After a period of time, if a growth is not observed on the slide, the doctor determines that E. coli (0157) is not present. If a growth is detected within a predetermined period of time, the doctor can be fairly sure that E. coli (0157) growth is present. Further confirmation of this identification can be made by conventional or molecular based systems .
EXAMPLE 8
A patient visits a doctor with symptoms which the doctor believes indicates the presence of helicoJbacter pylori . In order to determine the presence or absence of the helicobacter pylori , a receptacle containing an aqueous solution comprising:
Distilled Water 1 liter
Peptone 1 gram
NaCl 5 grams
Potassium Phosphate, Monobasic 2 grams
Urea 20 grams
Phenol Red 0.012 grams is prepared. A specimen from each patient is inoculated into the receptacle. After this, a slide with bound dextrose thereon is placed into the receptacle. After a period of time, if a growth is not observed on the slide, the doctor determines that helicobacter pylori is not present. If a growth is detected within a predetermined period of time, the doctor can be fairly sure that helicobacter pylori growth is present. Further confirmation of this identification can be made by conventional or molecular based systems.
EXAMPLE 9 A patient visits a doctor with symptoms which the doctor believes indicates the presence of klebsiella pneumoniae. In order to determine the presence or absence of the klebsiella pneumoniae, a receptacle containing an aqueous solution comprising: Distilled Water 1 liter
Peptone 10 grams
Dipotasium Phosphate 2 grams Eosin Y 0.4 grams Methylene Blue 0.065 grams is prepared. A specimen from each patient is inoculated into the receptacle. After this, a slide with bound sucrose thereon is placed into the receptacle. After a period of time, if a growth is not observed on the slide, the doctor determines that klebsiella pneumoniae is not present. If a growth is detected within a predetermined period of time, the doctor can be fairly sure that klebsiella pneumoniae growth is present. Further confirmation of this identification can be made by conventional or molecular based systems.
It will be appreciated that a method of determining the presence or absence of a nonparaffinophilic microorganism in a specimen and an associated apparatus has been disclosed. The method is effective and efficient and does not involve the use of expensive and complicated equipment. An associated apparatus is also disclosed.
While specific embodiments of the invention have been disclosed, it will be appreciated by those skilled in the art that various modifications and alterations to those details could be developed in light of the overall teachings of the disclosure. Accordingly, the particular arrangements disclosed are meant to be illustrative only and not limiting as to the scope of the invention which is to be given the full breadth of the appended claims and any and all equivalents thereof.

Claims

WHAT IS CLAIMED IS:
1. A method of determining the presence or absence of a nonparaffinophilic microorganism in a specimen taken from a patient, said method comprising: providing a receptacle containing an aqueous solution that does not contain a carbon source; inoculating said aqueous solution with said specimen; placing into said receptacle a slide having bound thereto a carbon source; and analyzing said slide after exposure to said specimen to determine the presence or absence of said nonparaffinophilic microorganism.
2. The method of Claim 1, including determining the presence or absence of staphylococcus aureus by using d-mannitol as said carbon source .
3. The method of Claim 2, wherein said aqueous solution includes distilled water, beef extract, peptone, sodium chloride and phenol red.
4. The method of Claim 3 , wherein said aqueous solution includes 1 liter distilled water, 1 gram beef extract, 10 grams peptone, 75 grams sodium chloride and 0.025 grams phenol red.
5. The method of Claim 1, including determining the presence or absence of streptococcus pneumoniae by using dextrose as said carbon source .
6. The method of Claim 5, wherein said aqueous solution includes distilled water, beef infusion, proteose and sodium chloride.
7. The method of Claim 6, wherein said aqueous solution includes 1 liter distilled water, 450 grams beef infusion, 20 grams proteose and 5 grams sodium chloride .
8. The method of Claim 1, including determining the presence or absence of shigella spp . by using lactose as said carbon source.
9. The method of Claim 8, wherein said aqueous solution includes distilled water, beef extract, peptone, bile salts, sodium citrate, sodium thiosulfate, ferric citrate, brilliant green and neutral red.
10. The method of Claim 9, wherein said aqueous solution includes 1 liter distilled water, 5 grams beef extract, 5 grams peptone,
8.5 grams bile salts, 8.5 grams sodium citrate, 8.5 grams sodium thiosulfate, 1 gram ferric citrate, 0.33 milligrams brilliant green and 0.025 grams neutral red.
11. The method of Claim 1, including determining the presence or absence of salmonella spp . by using lactose as said carbon source.
12. The method of Claim 11, wherein said aqueous solution includes distilled water, beef extract, peptone, bile salts, sodium citrate, sodium thiosulfate, ferric citrate, brilliant green and neutral red.
13. The method of Claim 12, wherein said aqueous solution includes 1 liter distilled water, 5 grams beef extract, 5 grams peptone,
8.5 grams bile salts, 8.5 grams sodium citrate, 8.5 grams sodium thiosulfate, 1 gram ferric citrate, 0.33 milligrams brilliant green and 0.025 grams neutral red.
14. The method of Claim 1, including determining the presence or absence of salmonella by using lactose as said carbon source.
15. The method of Claim 14, wherein said aqueous solution includes distilled water, tryptone, sodium selenite and sodium phosphate.
16. The method of Claim 15, wherein said aqueous solution includes 1 liter distilled water, 5 grams tryptone, 4 grams sodium selenite and 10 grams sodium phosphate.
17. The method of Claim 1, including determining the presence or absence of
E. coli by using lactose as said carbon source.
18. The method of Claim 17, wherein said aqueous solution includes distilled water, oxgall, peptone and brom cresol purple.
19. The method of Claim 18, wherein said aqueous solution includes 1 liter distilled water, 5 grams oxgall, 20 grams peptone and 0.01 grams brom cresol purple.
20. The method of Claim 1, including determining the presence or absence of
E. coli (0157) by using sorbitol as said carbon source.
21. The method of Claim 20, wherein said aqueous solution includes distilled water, oxgall, peptone and brom cresol purple.
22. The method of Claim 21, wherein said aqueous solution includes 1 liter distilled water, 5 grams oxgall, 20 grams peptone and 0.01 grams brom cresol purple.
23. The method of Claim 1, including determining the presence or absence of helicobacter pylori by using dextrose as said carbon source .
24. The method of Claim 23, wherein said aqueous solution includes distilled water, peptone, sodium chloride, potassium phosphate (monobasic), urea and phenol red.
25. The method of Claim 24, wherein said aqueous solution includes 1 liter distilled water, 1 gram peptone, 5 grams sodium chloride, 2 grams potassium phosphate (monobasic) , 20 grams urea and 0.012 grams phenol red.
26. The method of Claim 1, including determining the presence or absence of klebsiella pneumoniae by using sucrose as said carbon source .
27. The method of Claim 26, wherein said aqueous solution includes distilled water, peptone, dipotasium phosphate, eosin Y and methylene blue.
28. The method of Claim 27, wherein said aqueous solution includes 1 liter distilled water, 10 grams peptone, 2 grams dipotasium phosphate, 0.4 grams eosin Y and 0.065 grams methylene blue.
29. The method of Claim 1, including employing as said slide one coated with a gelatinous matrix containing said carbon source.
30. The method of Claim 1, including providing said slide by first adhering to said slide a plurality of gel beads and then bonding to said gel beads said carbon source .
31. The method of Claim 30, wherein said carbon source is ionically bound to said gel beads.
32. The method of Claim 30, wherein said carbon source is affinity bound to said gel beads .
33. The method of Claim 30, including adhering said gel beads to said slide by means of an adhesive.
34. The method of Claim 33, including employing as said adhesive collodion.
35. The method of Claim 1, including employing as said carbon source one or more of the group consisting of glucose, fructose, glycerol, mannitol, asparagine, casein, adonitol, 1-arabinose, cellobiose, dextrose, dulcitol, d-galactose, inositol, inulin, lactose, levulose (d- fructose) , maltose, d-mannitol, d-mannose, melibiose, raffinose, rhamnose, sucrose, salicin, d-sorbitol, trehalose and d-xylose.
36. The method of Claim 1, including employing as said specimen one selected from the group consisting of blood, stomach fluid, urine, cerebral spinal fluid, nasopharyngeal mucosa and saliva.
37. An apparatus to facilitate determination of the presence or absence of a nonparaffinophilic microorganism in a specimen taken from a patient, said apparatus comprising: a receptacle for holding an aqueous solution that does not contain a carbon source; and a slide having bound thereto a carbon source .
38. The apparatus of Claim 37, wherein said nonparaffinophilic microorganism is staphylococcus aureus; and said carbon source is d-mannitol.
39. The apparatus of Claim 38, wherein said aqueous solution includes distilled water, beef extract, peptone, sodium chloride and phenol red.
40. The apparatus of Claim 39, wherein said aqueous solution includes 1 liter distilled water, 1 gram beef extract, 10 grams peptone, 75 grams sodium chloride and 0.025 grams phenol red.
41. The apparatus of Claim 37, wherein said nonparaffinophilic microorganism is streptococcus pneumoniae; and said carbon source is dextrose.
42. The apparatus of Claim 1, wherein said aqueous solution includes distilled water, beef infusion, proteose and sodium chloride.
43. The apparatus of Claim 42, wherein said aqueous solution includes 1 liter distilled water, 450 grams beef infusion, 20 grams proteose and 5 grams sodium chloride.
44. The apparatus of Claim 37, wherein said nonparaffinophilic microorganism is shigella spp . ; and said carbon source is lactose.
45. The apparatus of Claim 44, wherein said aqueous solution includes distilled water, beef extract, peptone, bile salts, sodium citrate, sodium thiosulfate, ferric citrate, brilliant green and neutral red.
46. The apparatus of Claim 45, wherein said aqueous solution includes 1 liter distilled water, 5 grams beef extract, 5 grams peptone, 8.5 grams bile salts, 8.5 grams sodium citrate, 8.5 grams sodium thiosulfate, 1 gram ferric citrate, 0.33 milligrams brilliant green and 0.025 gram neutral red.
47. The apparatus of Claim 37, wherein said nonparaffinophilic microorganism is salmonella spp . ; and said carbon source is lactose.
48. The apparatus of Claim 47, wherein said aqueous solution includes distilled water, beef extract, peptone, bile salts, sodium citrate, sodium thiosulfate, ferric citrate, brilliant green and neutral red.
49. The apparatus of Claim 48, wherein said aqueous solution includes 1 liter distilled water, 5 grams beef extract, 5 grams peptone,
8.5 grams bile salts, 8.5 grams sodium citrate, 8.5 grams sodium thiosulfate, 1 gram ferric citrate, 0.33 milligrams brilliant green and 0.025 grams neutral red.
50. The apparatus of Claim 37, wherein said nonparaffinophilic microorganism is salmonella ; and said carbon source is lactose.
51. The apparatus of Claim 50, wherein said aqueous solution includes distilled water, tryptone, sodium selenite and sodium phosphate.
52. The apparatus of Claim 51, wherein said aqueous solution includes 1 liter distilled water, 5 grams tryptone, 4 grams sodium selenite and 10 grams sodium phosphate.
53. The apparatus of Claim 37, wherein said nonparaffinophilic microorganism is E . coli ; and said carbon source is lactose.
54. The apparatus of Claim 53, wherein said aqueous solution includes distilled water, oxgall, peptone and brom cresol purple.
55. The apparatus of Claim 54, wherein said aqueous solution includes 1 liter distilled water, 5 grams oxgall, 20 grams peptone and 0.01 grams brom cresol purple.
56. The apparatus of Claim 37, wherein said nonparaffinophilic microorganism is E. coli (0157) ; and said carbon source is sorbitol .
57. The apparatus of Claim 56, wherein said aqueous solution includes distilled water, oxgall, peptone and brom cresol purple.
58. The apparatus of Claim 57, wherein said aqueous solution includes 1 liter distilled water, 5 grams oxgall, 20 grams peptone and 0.01 grams brom cresol purple.
59. The apparatus of Claim 37, wherein said nonparaffinophilic microorganism is helicobacter pylori ; and said carbon source is dextrose.
60. The apparatus of Claim 59, wherein said aqueous solution includes distilled water, peptone, sodium chloride, potassium phosphate (iTionojbasic) , urea and phenol red.
61. The apparatus of Claim 60, wherein said aqueous solution includes 1 liter distilled water, 1 gram peptone, 5 grams sodium chloride, 2 grams potassium phosphate (monobasic) , 20 grams urea and 0.012 grams phenol red.
62. The apparatus of Claim 37, wherein said nonparaffinophilic microorganism is klebsiella pneumoniae; and said carbon source is sucrose.
63. The apparatus of Claim 62, wherein said aqueous solution includes distilled water, peptone, dipotasium phosphate, eosin Y and methylene blue.
64. The apparatus of Claim 63, wherein said aqueous solution includes 1 liter distilled water, 10 grams peptone, 2 grams dipotasium phosphate, 0.4 grams eosin Y and 0.065 grams methylene blue .
65. The apparatus of Claim 37, wherein said slide is coated with a gelatinous matrix containing said carbon source.
66. The apparatus of Claim 37, wherein said slide is coated with a plurality of gel beads which have bound thereon said carbon source.
67. The apparatus of Claim 66, wherein said carbon source is ionically bound to said gel beads .
68. The apparatus of Claim 66, wherein said carbon source is affinity bound to said gel beads .
69. The apparatus of Claim 66, wherein said gel beads are adhered to said slide by an adhesive.
70. The apparatus of Claim 69, wherein said adhesive is collodion.
71. The apparatus of Claim 37, wherein said carbon source is one or more of the group consisting of glucose, fructose, glycerol, mannitol, asparagine, casein, adonitol, 1-arabinose, cellobiose, dextrose, dulcitol, d-galactose, inositol, inulin, lactose, levulose ( d-fructose) , maltose, d-mannitol, d-mannose, melibiose, raffinose, rhamnose, sucrose, salicin, d-sorbitol, trehalose and d-xylose.
72. The apparatus of Claim 37, wherein said specimen is one selected from the group consisting of blood, stomach fluid, urine, cerebral spinal fluid, nasopharyngeal mucosa and saliva.
PCT/US1998/009421 1997-05-19 1998-05-08 Method and apparatus for determining nonparaffinophilic microorganisms WO1998053043A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU73739/98A AU7373998A (en) 1997-05-19 1998-05-08 Method and apparatus for determining nonparaffinophilic microorganisms

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/858,350 US5854013A (en) 1995-09-14 1997-05-19 Method of determining the presence or absence of a nonparaffinophilic microorganism in a specimen
US08/858,350 1997-05-19

Publications (1)

Publication Number Publication Date
WO1998053043A1 true WO1998053043A1 (en) 1998-11-26

Family

ID=25328102

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1998/009421 WO1998053043A1 (en) 1997-05-19 1998-05-08 Method and apparatus for determining nonparaffinophilic microorganisms

Country Status (3)

Country Link
US (2) US5854013A (en)
AU (1) AU7373998A (en)
WO (1) WO1998053043A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6087156A (en) * 1996-09-16 2000-07-11 R&F Laboratories, Inc. Method for isolation and identification of Escherichia coli 0157:H7 and plating media for said process
US5981210A (en) * 1997-11-13 1999-11-09 Infectech, Inc. Method for determining a presence or absence of a nonparaffinophilic hydrophobic microorganism in a body specimen by using a DNA extraction procedure and a novel DNA extraction procedure
US7008777B2 (en) * 2001-10-15 2006-03-07 Barry J. Marshall System for the detection of urease and method for using same
US6998250B2 (en) 2001-10-15 2006-02-14 Donald J. McMichael Method for detecting Helicobacter pylori
US6929926B2 (en) 2001-10-15 2005-08-16 Barry J. Marshall Composition for the detection of gastrointestinal disorders
USD484988S1 (en) 2001-12-17 2004-01-06 Kimberly-Clark Worldwide, Inc. Diagnostic test kit with specimen-handling tool
US6783976B2 (en) 2001-12-21 2004-08-31 Kimberly-Clark Worldwide, Inc. Carrier and specimen-handling tool for use in diagnostic testing
US7316910B2 (en) * 2004-06-03 2008-01-08 Kinase Scientific, Llc Rapid test for hemolytic streptococcus
WO2006135750A2 (en) * 2005-06-10 2006-12-21 Nanologix, Inc. Method for utilizing nonparaffinophilic microorganisms for producing specific waste degradation
GB0816559D0 (en) 2008-09-10 2008-10-15 Solus Biolog Ltd Composition and Assay Method for the detection of pathogenic bacteria
ES2627344T3 (en) 2011-07-13 2017-07-27 Foodchek Systems, Inc. Culture medium, method to grow listeria and method to detect listeria
CN108911120A (en) * 2018-07-18 2018-11-30 山西龙盘微生物科技有限公司 A kind of acclimation method for daily use chemicals cleaning product activated sludge of degrading

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721112A (en) * 1995-09-14 1998-02-24 Infectech, Inc. Method of determining the presence or absence of a nonparaffinophilic microoganism in a specimen and an associated apparatus

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3826717A (en) * 1973-02-26 1974-07-30 V Gilbert Quantitative antibiotic test container
US3966552A (en) * 1975-04-14 1976-06-29 Smithkline Corporation Device for making a culture of micro-organisms
US4048016A (en) * 1975-04-25 1977-09-13 The United States Of America As Represented By The Department Of Health, Education And Welfare Identification of non-fermentative gram-negative bacteria
US4252897A (en) * 1978-05-03 1981-02-24 Axford Herbert George Method and apparatus for bacteria testing
FR2525233B1 (en) * 1982-04-14 1985-12-06 Lille Inst Pasteur MICROBIOLOGICAL CULTURE DEVICE
US4683201A (en) * 1984-10-09 1987-07-28 Eli Lilly And Company Antibiotic A80190-producing Actinomadura oligospora and process
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
IL76189A0 (en) * 1985-08-26 1985-12-31 Rehovot Bio Medic Associates Device for cultivating bacteria
US5374538A (en) * 1989-03-01 1994-12-20 Orion-Yhtyma Oy Method and kit for detection or quantification of streptococcus mutans and streptococcus sobrinus
US5698414A (en) * 1989-10-24 1997-12-16 Infectech, Inc. Method and apparatus for testing paraffinophilic microorganisms for antimicrobial agent sensitivity
US5316918A (en) * 1989-10-24 1994-05-31 Infectech, Inc. Method and apparatus for testing MAI (mycobacterium avium-intracellulare) for antimicrobial agent sensitivity
US5153119A (en) * 1989-10-24 1992-10-06 Infectech Inc. Method for speciating and identifying mai (mycobacterium avium-intracellulare)
US5663056A (en) * 1995-09-14 1997-09-02 Infectech, Inc. Method for determining the antimicrobial agent sensitivity of a nonparaffinophilic microorganism and an associated apparatus
US5750363A (en) * 1995-09-14 1998-05-12 Infectech, Inc. Method for determining the antimicrobial agent sensitivity of a nonparaffinophilic microorganism and an associated apparatus
US5637501A (en) * 1995-09-28 1997-06-10 Infectech, Inc. Apparatus for automatically testing the antibiotic sensitivity of a paraffinophilic microorganism
US5641645A (en) * 1995-11-09 1997-06-24 Infectech, Inc. Method for determining the antimicrobial agent sensitivity of a nonparaffinophilic microorganism using various milieus and an associated apparatus
US5707824A (en) * 1995-11-09 1998-01-13 Infectech, Inc. Method of determining the presence or absence of a paraffinophilic microorganism
US5639675A (en) * 1995-11-09 1997-06-17 Infectech, Inc. Method of identifying a nonparaffinophilic microorganism using various milieus and an associated apparatus

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721112A (en) * 1995-09-14 1998-02-24 Infectech, Inc. Method of determining the presence or absence of a nonparaffinophilic microoganism in a specimen and an associated apparatus

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
MISHRA S. K., ET AL.: "OBSERVATIONS ON PARAFFIN BAITING AS A LABORATORY DIAGNOSTIC PROCEDURE IN NOCARDIOSIS.", MYCOPATHOLOGIA ET MYCOLOGIA APPLICATA, DEN HAAG, NL, vol. 51., no. 02/03., 1 January 1973 (1973-01-01), NL, pages 147 - 157., XP002911599, ISSN: 0027-5530, DOI: 10.1007/BF02141106 *
OLLAR R. A., ET AL.: "THE USE OF PARAFFIN WAX METABOLISM IN THE SPECIATION OF MYCOBACTERIUM AVIUM-INTRACELLULARE.", TUBERCLE., LONGMAN GROUP UK LTD., HARLOW., GB, vol. 71., 1 January 1990 (1990-01-01), GB, pages 23 - 28., XP002911597, ISSN: 0041-3879, DOI: 10.1016/0041-3879(90)90056-E *
OLLAR R.-A.: "A PARAFFIN BAITING TECHNIQUE THAT ENABLES A DIRECT MICROSCOPIC VIEW OF "IN-SITU" MORPHOLOGY OF NOCARDIA ASTEROIDES WITH THE ACID-FAST OR FLUORESCENCE STAINING PROCEDURES.", ZENTRALBLATT FUER BAKTERIOLOGIE, PARASIETENKUNDE,INFEKTIONSKRANKHEITEN UND HYGIENE. 1. ABTEILUNG. ORIGINALE.REIHE A, MEDIZINISCHE MIKROBIOLOGIE UND PARASITOLOGIE., FISCHER, STUTTGART., DE, vol. 234., 1 January 1976 (1976-01-01), DE, pages 81 - 90., XP002911598, ISSN: 0300-9688 *

Also Published As

Publication number Publication date
US5854013A (en) 1998-12-29
US5962306A (en) 1999-10-05
AU7373998A (en) 1998-12-11

Similar Documents

Publication Publication Date Title
Kloos et al. Simplified scheme for routine identification of human Staphylococcus species
Gillespie Medical microbiology illustrated
US5498528A (en) Detection of helicobacter pylori
US5854013A (en) Method of determining the presence or absence of a nonparaffinophilic microorganism in a specimen
EP0717112B1 (en) Method and apparatus for testing MAI (Mycobacterium Avium-Intracellulare) for antibiotic sensitivity
Ellner et al. Recovery and identification of anaerobes: a system suitable for the routine clinical laboratory
US5639675A (en) Method of identifying a nonparaffinophilic microorganism using various milieus and an associated apparatus
US5641645A (en) Method for determining the antimicrobial agent sensitivity of a nonparaffinophilic microorganism using various milieus and an associated apparatus
US5663056A (en) Method for determining the antimicrobial agent sensitivity of a nonparaffinophilic microorganism and an associated apparatus
US5750363A (en) Method for determining the antimicrobial agent sensitivity of a nonparaffinophilic microorganism and an associated apparatus
US5721112A (en) Method of determining the presence or absence of a nonparaffinophilic microoganism in a specimen and an associated apparatus
Citron Specimen collection and transport, anaerobic culture techniques, and identification of anaerobes
Jousimies-Somer et al. Problems encountered in clinical anaerobic bacteriology
JP4711846B2 (en) 方法 How to determine acute mastitis
MXPA98002029A (en) Determination of microorganisms not parafinofili
US5882920A (en) Apparatus for determining the presence or absence of a paraffinophilic microorganism
Sümerkan et al. Brucella detection in blood: comparison of the BacT/Alert standard aerobic bottle, BacT/Alert FAN aerobic bottle and BacT/Alert enhanced FAN aerobic bottle in simulated blood culture
DeGirolami et al. Evaluation of a direct fluorescent antibody staining method for rapid identification of members of the Bacteroides fragilis group
CA2237165A1 (en) A method of identifying a nonparaffinophilic microorganism using various milieus and an associated apparatus
CA2237167A1 (en) A method for determining the antimicrobial agent sensitivity of a nonparaffinophilic microorganism using various milieus and an associated apparatus
MXPA98002030A (en) A method for determining the sensitivity of antimicrobial agent of a non-parafinophilic microorganism and an associated apparatus
Meiring, JA,* Kemp, E.,* Jennings, DL,** Mdhlovu, M.*** & Koornhof High-level penicillin-resistant gonococcal infections in Port Elizabeth
CA2237166A1 (en) Method and apparatus to determine paraffinophilic microorganisms

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 1998550413

Format of ref document f/p: F

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA